iSpecimen Inc. Retained Earnings
iSpecimen Inc. (ISPC) had Retained Earnings of -$85.99 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$85.99M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$84.63M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$82.35M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$77.35M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$85.99M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$84.63M 10-Q · filed 2026-05-18 |
| 2025-12-31 | -$82.35M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$77.35M 10-Q · filed 2025-11-17 |
| 2025-06-30 | -$74.57M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$73.52M 10-Q · filed 2025-05-19 |
| 2024-12-31 | -$71.86M 10-K · filed 2026-04-01 |
| 2024-09-30 | -$65.82M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$64.38M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$62.27M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$59.36M 10-K · filed 2025-04-14 |
| 2023-09-30 | -$56.29M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$54.18M 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$50.70M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$48.27M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$46.11M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$43.01M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$40.40M 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$38.02M 10-K/A · filed 2023-03-30 |
| 2021-09-30 | -$35.97M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$34.42M 10-Q · filed 2021-08-10 |
| 2020-12-31 | -$29.06M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |